Verition Fund Management’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,348
Closed -$439K 3370
2024
Q1
$439K Buy
+1,348
New +$331K ﹤0.01% 2082
2023
Q4
Sell
-5,000
Closed -$945K 2764
2023
Q3
$996K Buy
5,000
+2,507
+101% +$593K 0.01% 1084
2023
Q2
$712K Buy
+2,493
New +$692K 0.01% 1054
2023
Q1
Sell
-2,427
Closed -$499K 2661
2022
Q4
$499K Sell
2,427
-2,237
-48% -$566K 0.01% 1240
2022
Q3
$1.3M Buy
4,664
+1,031
+28% +$262K 0.01% 1208
2022
Q2
$695K Sell
3,633
-790
-18% -$139K 0.01% 1235
2022
Q1
$917K Sell
4,423
-1,893
-30% -$312K 0.01% 1532
2021
Q4
$1.13M Buy
6,316
+2,189
+53% +$432K 0.01% 1221
2021
Q3
$850K Buy
4,127
+1,364
+49% +$268K 0.01% 999
2021
Q2
$524K Buy
+2,763
New +$452K ﹤0.01% 1067

Other funds holding SWAV

Verition Fund Management's SWAV Position: Q2 2024 in Review

Verition Fund Management sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,348 shares — an estimated $439K sold.

Verition Fund Management first reported a position in SWAV in Q2 2021 and held it in 10 quarters. The position peaked at $1.3M in Q3 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Verition Fund Management reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Verition Fund Management sold 1,348 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $439K.
  • Verition Fund Management first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Verition Fund Management's Shockwave Medical, Inc. Common Stock position peaked at $1.3M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Verition Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.